Loss of Cdx2 Expression in Primary Tumors and Lymph Node Metastases is Specific for Mismatch Repair-Deficiency in Colorectal Cancer

Keywords

MLH1, MSH2, Medicine, Microsatellite instability, CDX2

References

• Reduced CDX2 Expression Predicts Poor Overall Survival in Patients with Colorectal CancerKwang Dae Hong, Dooseok Lee, Youngseok Lee — 2013
• Use of multivariate analysis to suggest a new molecular classification of colorectal cancerEnric Domingo, Rajarajan Ramamoorthy, Dahmane Oukrif — 2013
• CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites.Lindsey B. De Lott, Carl Morrison, Saul Suster — 2005
• Intestine-specific transcription factor Cdx2 induces E-cadherin function by enhancing the trafficking of E-cadherin to the cell membrane.Shinsuke Funakoshi, Jianping Kong, Mary Ann S. Crissey — 2010
• The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cellsI Gross, Isabelle Duluc, Tarek Benameur — 2008
• Effects of Homeodomain Protein CDX2 Expression on the Proliferation and Migration of Lovo Colon Cancer CellsJianbao Zheng, Xuejun Sun, Jie Qi — 2011
• Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and β-catenin activity in colon cancer cells.Isabelle Hinkel, Isabelle Duluc, Elisabeth Martin — 2012
• The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancerBritta Halvarsson, Annika Lindblom, Eva Rambech — 2006
• Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectumJeremy R. Jass, Joanne Young, Barbara Leggett — 2000
• CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic CarcinomasRobert Werling, Hadi Yaziji, Carlos E. Bacchi — 2003
• Molecular heterogeneity of colorectal cancer: Implications for cancer control.Jeremy R. Jass — 2007
• Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotypeMichael D. Walsh, Mark Clendenning, Elizabeth Williamson — 2013
• Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair statusAlessandro Lugli, Alexandar Tzankov, Inti Zlobec — 2008
• Clinicopathological and protein characterization of BRAF‐ and K‐RAS‐mutated colorectal cancer and implications for prognosisInti Zlobec, Michel Bihl, Heike Schwarb — 2010
• Up and downregulation of p16Ink4a expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancerLydia Kriegl, Jens Neumann, Michael Vieth — 2011
• CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.Nicholas J. Hawkins, Mark Norrie, Kay Cheong — 2002
• Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.Parham Minoo — 2010
• Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer: Implications for Clinical and Pathology PracticeYoshifumi Baba, Katsuhiko Nosho, Kaori Shima — 2009
• Classification of colorectal cancer based on correlation of clinical, morphological and molecular featuresJ R Jass — 2007
• V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4aLinda Carragher, Kimberley R. Snell, Susan Giblett — 2010

Cited by

• Loss of CDX2 gene expression is associated with DNA repair proteins and is a crucial member of the Wnt signaling pathway in liver metastasis of colorectal cancer誠也 大築, 敦夫 瀧野, 拓郎 森 — 2018
• Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markersMaysa Al‐Hussaini, Noreen Dissi, Cyrine Souki — 2016
• Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.Jeong Mo Bae — 2015
• Towards a Molecular Classification of Colorectal CancerAlessandro Lugli — 2015
• CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer.Jørgen Olsen, J. Olsen, Susanne Eiholm — 2016
• The clinical perspectives of CDX2 expression in colorectal cancer: a qualitative systematic review.Jesper Olsen, Maiken Lise Marcker Espersen, Per Jess — 2014
• SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancerIda Lundberg, Sofia Edin, Vincy Eklöf — 2016
• Towards a molecular classification of colorectal cancerM. Ridder, J. Gérard — 2015
• Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal CancerGuozhong Jiang, Chenglin Luo, Miaomiao Sun — 2016
• Epigenetic Biomarkers in Colorectal CancerMukesh Verma, Vineet Kumar — 2016
• Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivoJianbao Zheng, Sai He, Jie Qi — 2017
• Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinomaLuca Reggiani Bonetti, Simona Lionti, Enrica Vitarelli — 2017
• Association of CDX2 Expression With Survival in Early Colorectal Cancer: A Systematic Review and Meta‐analysisGianluca Tomasello, Sandro Barni, Luca Turati — 2018
• The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancerJens Neumann, Volker Heinemann, Jutta Engel — 2018
• Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohortsTorben Frøstrup Hansen, Sanne Kjær‐Frifeldt, Ann Christina Eriksen — 2018
• CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathwayJanina Graule, Kristin Uth, Elia Fischer — 2018
• Architects meets Repairers: The interplay between homeobox genes and DNA repair.Bruno César Feltes — 2019
• Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.Heather Dawson, Francesca Galuppini, Peter Träger — 2019
• Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancerWeimin Xu, Yilian Zhu, Wei Feng Shen — 2019
• Immunohistochemical expression of CDX2 gene in colorectal carcinomaTavga Hushair Dizeyi, Rafal Abdulrazaq Al-Rawi, Ava Taher Ismael — 2019

Related papers

• Implication of expression of MMR proteins and clinicopathological characteristics in gastric cancerRenu Verma, Puja Sakhuja, Ritu Srivastava — 2020
• DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.Anand Rajan, Christopher K.H. Burris, Nicholas T. Iliff — 2014
• Detection of Mismatch Repair and Microsatellite Instability in Colorectal Cancer PatientsMuhammad Ishaque Faizee — 2020
• Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in PolandKatarzyna Karpińska-Kaczmarczyk, Magdalena Lewandowska, Małgorzata Ławniczak — 2016
• Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.Adrian Gologan, Antonia R. Sepulveda — 2005
• [Microsatellite instability of bilateral breast carcinomas is not linked to down-regulated expression of DNA mismatch repair genes].E Sh Kuligina, N Morreau, Imianitov En — 2010
• [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].Y Liu, Yundi Guo, Yang Luo — 2021
• Cancerogenesis in colorectal neoplasms: Evidence from early onset colorectal cancerMahsa Molaei, Babak Khoshkrood Mansoori, Somayeh Ghiasi — 2012